News | Cardiovascular Business | August 10, 2022

ASNC Joins Effort to Stop Proposed Cuts in CY2023 Physician Fee Schedule

On July 27, ASNC joined a coalition of more than 100 medical societies urging Congress to pass legislation that provides at least a 4.5 percent conversion factor adjustment and waives a statutory PAYGO requirement that will otherwise result in a 4 percent sequestration next year on top of the existing 2 percent sequestration.

Getty Images


August 10, 2022 — On July 27, ASNC joined a coalition of more than 100 medical societies urging Congress to pass legislation that provides at least a 4.5 percent conversion factor adjustment and waives a statutory PAYGO requirement that will otherwise result in a 4 percent sequestration next year on top of the existing 2 percent sequestration. The letter specifies that any legislation should include a one-year inflationary update based on the Medicare Economic Index.
The letter is in response to the CY2023 Medicare Physician Fee Schedule Proposed Rule that lays out a 4.5 percent cut to the conversion factor next year, the majority of which is due to the expiration of a 3 percent adjustment provided by Congress. The conversion factor forms the basis of Medicare payments. Therefore, proposed cuts affect all services paid under the physician fee schedule.
ASNC and other societies are seeking payment reforms from Congress that will establish financial stability to clinicians and guarantee access to Medicare beneficiaries now and in the future. The Medicare payment system continues to be jeopardized by the effects of budget neutrality requirements and the absence of inflationary updates as expenses for physician practitioners continue to rise.

For more information: https://www.asnc.org/ 


Related Content

News | Cardiovascular Business

July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing ...

Home July 29, 2024
Home
News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
Subscribe Now